Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02889900
Title Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer (CONCERTO)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

ovary serous adenocarcinoma

peritoneal carcinoma

fallopian tube carcinoma

ovarian clear cell carcinoma

endometrioid ovary carcinoma

Therapies

Cediranib + Olaparib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Mobile Alabama 36604 United States Details
Research Site Anchorage Alaska 99508 United States Details
Research Site Downey California 90241 United States Details
Research Site Greenbrae California 94904 United States Details
Research Site Orange California 92868 United States Details
Research Site San Diego California 92123 United States Details
Research Site San Francisco California 94115 United States Details
Research Site West Hollywood California 90048 United States Details
Research Site Miami Florida 33136 United States Details
Research Site Miami Florida 33176 United States Details
Research Site Orlando Florida 32804 United States Details
Research Site Augusta Georgia 30901 United States Details
Research Site Newnan Georgia 30265 United States Details
Research Site Fort Wayne Indiana 46804 United States Details
Research Site Westwood Kansas 66205 United States Details
Research Site Covington Louisiana 70433 United States Details
Research Site Towson Maryland 21204 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Billings Montana 59101 United States Details
Research Site New York New York 10032 United States Details
Research Site Rochester New York 14642 United States Details
Research Site Charlotte North Carolina 28204 United States Details
Research Site Winston-Salem North Carolina 27103 United States Details
Research Site Knoxville Tennessee 37920 United States Details
Research Site Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field